1Pfaller MA,Diekema DJ,Gibbs DL, et al. Geographic varia- tion in the frequency of isolation and fluconazole and voricon azole susceptibilities of Candida glabrata : an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program[J]. Diagnostic Microbiology & Infectious Disease, 2010,67 (2) : 162-171.
2Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10. 5-year analysis of susceptibilities of Candida Species to flueonazole and voriconazole as determined by CLSI standardized disk diffusion[J]. J Clin Microbial, 2010, 48(4): 1366-1377.
3Khot PD,Ko DL, Fredricks DN. Sequencing and Analysis of Fungal rRNA Operons for Development of Broad-Range Fungal PCR Assays[J]. APPLIED AND ENVIRONMEN- TAL MICROBIOLOGY, 2009,75 (6) : 1559-1565.
4Babiker WM, Merz WG, Merz WG, et al. Evaluation of nucle- ic acid sequencing of the D1/D2 region of the large subunit of the 28S rDNA and the internal transcribed spacer region u sing SmartGene IDNSlcorrected: software for identification of filamentous fungi in a clinical laboratory[J]. J Mol Diagn, 2012,14(6) :634.
5Jang JH, Lee JH, Ki CS, et al. Identification of clinical mold i- solates by sequence analysis of the internal transcribed spacer region, ribosomal large-subunit D1/D2, and β-tubulin[J]. Ann Lab Med,2012,32(2) :126-132.
6Blaalid R, Kumar S, Nilsson RH, et al. ITS1 versus ITS2 as DNA metabarcodes for fungi[J]. Mol Ecol Resour, 2013,13 (2) :218-224.
7Van Burik J A, Myerson D, Schreckhise RW, et al. Panfungal PCR Assay for Detection of Fungal Infection in Human Blood Specimens [J]. J Clin Microbiol, 1998, 36 ( 5), 1169- 1175.
8Sugawara Y, Nakase K, Nakamura A, et al. Clinical Utility of a Panfungal Polymerase Chain Reaction Assay for Invasive Fungal diseases in Patients with Haematologic Disorders[,J]. Eur J Haematol,2013,90(4) ,331-339.
9Mufioz-Cadavid C,Rudd S,Zaki SR,et al. Improving Molecu- lar Detection of Fungal DNA in Formalin-Fixed Paraffin-Em- bedded Tissues:Comparison of Five Tissue DNA Extraction Methods Using Panfungal PCR[J]. J Clin Microbiol, 2010,48 (6) : 2147-2153.
10Heo SM, Sung RS, Scannapieco FA, et al. Genetic relation- ships between Candida albicans strains isolated from dental plaque,trachea, and bronchoalveolar lavage fluid from me- chanically ventilated intensive care unit patients[J]. J Oral Microbiol, 2011,3 : 6362.
3Martin GS,Mannino DM,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000.N Engl J Med,2003,348(16):1546-1554.
4Marr KA,Carter RA,Crippa F,et al.Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.Clin Infect Dis,2002,34(7):909-917.
5Cornillet A,Camus C,Nimubona S,et al.Comparison of epidemiological,clinical,and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients:a 6-year survey.Clin Infect Dis,2006,43(5):577-584.
6Pfaller MA,Diekema DJ.Rare and emerging opportunistic fungal pathogens:concern for resistance beyond Candida albicans and Aspergillus fumigatus.J Clin Microbiol,2004,42(10):4419-4431.
7Baddley JW,Pappas PG,Smith AC,et al.Epidemiology of Aspergillus terreus at a university hospital.J Clin Microbiol,2003,41(12):5525-5529.
9Walsh TJ,Groll A,Hiemenz J,et al.Infections due to emerging and uncommon medically important fungal pathogens.Clin Microbiol Infect,2004,10(Suppl 1):48-66.
10Diekema DJ,Messer SA,Hollis RJ,et al.Activities of caspofungin,itraconazole,posaconazole,ravuconazole,voriconazole,and amphotericin B against 448 recent clinical isolates of filamentous fungi.J Clin Microbiol,2003,41 (8):3623-3626.
1Brissaud O, Guichoux J, Harambat J, et al. Invasive fungal dis- ease in Picu= epidemiology and risk factors[J]. Ann Intensive Care, 2012, 2(1): 22.
2Roilides E. Invasive candidiasis in neonates and children[J]. Early Hum Dev, 2011(87) : S75-S76.
3Barton RC. Laboratory Diagnosis o{ invasive pulmonary aspergil- iosis: from Diagnosis to prediction of outcome[J]. Scientifica (Cairo), 2013. http://dx, doi. org/10. 1155/2013/4,59405.
4Yasemin O, Kiraz N. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods[J]. Expert Anti Infect Ther, 2011, 9(3):289-98.
5Jain S, Das S, Gupta N, et al. Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India[J]. Med Myeol, 2013, 51(2): 164-9.
6Jaijakul S, Vazquez JA, Swanson RN, et al. (1, 3)-β-D-Glucan as a prognostic marker of treatment response in invasive candidia sis[J]. Clin Infect Dis, 2012, 55(4): 521-6.
7Lu Y, Chen Y, Guo Y, et al. Diagnosis of invasive ungal disease using serum(1, 3)-b-D-gluean: a bivariate meta analysis[J]. In- tern Med, 2011, 50(22): 2783-91.
8Lamoth F, Cruciani M, Mengoli C, et al. B Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-a- nalysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)[J]. Clin Infect Dis, 2012, 54 (5) : 633-43.
9Karageorgopoulos DE, Qu JM, Korbila IP, et al. Accuracy of b-glucan for the diagnosis of Pneumocystisjirovecii pneumonia: a metaanalysis[J]. ClinMicrobiolInfect, 2013, 19(1): 39-49.
10Mortensen KL, Johansen HK, Fuursted K, et al. A prospective survey of Aspergiglus slop. in respiratory tract samples: preva- lence, clinical impact and antifungal susceptibility[J]. Eur J Clin Microbiol Infect Dis, 2011, 30(11): 1355-63.
